Alexander T Nelson, Anne K Harris, Dave Watson, Junne Kamihara, Kenneth S Chen, Jennifer N Stall, Kyle M Devins, Robert H Young, Damon R Olson, Paige H R Mallinger, Sarah G Mitchell, Lindsey M Hoffman, Gail Halliday, Amina M Suleymanova, Julia L Glade Bender, Yoav H Messinger, Cynthia E Herzog, Amanda L Field, A Lindsay Frazier, Douglas R Stewart, Louis P Dehner, D Ashley Hill, Deborah F Billmire, Dominik T Schneider, Kris Ann P Schultz
OBJECTIVE: Sertoli-Leydig cell tumors (SLCTs) are rare sex cord-stromal tumors, representing <0.5% of all ovarian tumors. We sought to describe prognostic factors, treatment and outcomes for individuals with ovarian SLCT. METHODS: Individuals with SLCT were enrolled in the International Pleuropulmonary Blastoma/DICER1 Registry and/or the International Ovarian and Testicular Stromal Tumor Registry. Medical records were systematically abstracted, and pathology was centrally reviewed when available...
April 22, 2024: Gynecologic Oncology